Page last updated: 2024-12-08

dithiane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dithiane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID136335
CHEBI ID47844
SCHEMBL ID20606
MeSH IDM0403422

Synonyms (19)

Synonym
nsc 521078
unii-c4kjf9qfr3
c4kjf9qfr3 ,
505-20-4
1,2-dithiane
inchi=1/c4h8s2/c1-2-4-6-5-3-1/h1-4h
nsc-521078
1,2-dithiacyclohexane
o-dithiane
tetramethylene disulfide
nsc521078
1,2-dithian
CHEBI:47844
dithiane
51330-42-8
[1,2]dithiane
SCHEMBL20606
Q1986981
DTXSID001026590
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dithiane
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.13)18.7374
1990's0 (0.00)18.2507
2000's22 (46.81)29.6817
2010's22 (46.81)24.3611
2020's2 (4.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.45 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index69.42 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (97.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]